GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Accumulated other comprehensive income (loss)

Intelgenx Technologies (FRA:0IL) Accumulated other comprehensive income (loss) : €-1.97 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Intelgenx Technologies's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-1.97 Mil.

Intelgenx Technologies's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€-2.03 Mil) to Dec. 2023 (€-2.25 Mil) but then increased from Dec. 2023 (€-2.25 Mil) to Mar. 2024 (€-1.97 Mil).

Intelgenx Technologies's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-1.21 Mil) to Dec. 2022 (€-2.11 Mil) and declined from Dec. 2022 (€-2.11 Mil) to Dec. 2023 (€-2.25 Mil).


Intelgenx Technologies Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Intelgenx Technologies's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Accumulated other comprehensive income (loss) Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.75 -0.70 -1.21 -2.11 -2.25

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.08 -2.20 -2.03 -2.25 -1.97

Intelgenx Technologies Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Intelgenx Technologies Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies (FRA:0IL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines